About Us Services Careers FAQ Contact Us 0
Home Speciality Chemicals Biotech Ingredients Market Trends, Growth & Share-2033
Biotech Ingredients Market

Biotech Ingredients Market Size, Share & Trends Analysis Report By Type (Active Pharmaceuticals Ingredients (APIs), Biosimilars), By Products (Monoclonal antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), By Expression System (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRSC3497DR
Author : Vrushali Bothare
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Biotech Ingredients Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    5. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Active Pharmaceuticals Ingredients (APIs)
          1. By Value
        3. Biosimilars
          1. By Value
      2. By Products
        1. Introduction
          1. Products By Value
        2. Monoclonal antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Hormones and Growth Factors
          1. By Value
        5. Cytokines
          1. By Value
        6. Fusion Proteins
          1. By Value
        7. Therapeutic Enzymes
          1. By Value
        8. Blood Factors
          1. By Value
      3. By Expression System
        1. Introduction
          1. Expression System By Value
        2. Mammalian Expression Systems
          1. By Value
        3. Microbial Expression Systems
          1. By Value
        4. Yeast Expression Systems
          1. By Value
        5. Plant Expression Systems
          1. By Value
        6. Insect Expression Systems
          1. By Value
    6. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    5. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Active Pharmaceuticals Ingredients (APIs)
          1. By Value
        3. Biosimilars
          1. By Value
      2. By Products
        1. Introduction
          1. Products By Value
        2. Monoclonal antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Hormones and Growth Factors
          1. By Value
        5. Cytokines
          1. By Value
        6. Fusion Proteins
          1. By Value
        7. Therapeutic Enzymes
          1. By Value
        8. Blood Factors
          1. By Value
      3. By Expression System
        1. Introduction
          1. Expression System By Value
        2. Mammalian Expression Systems
          1. By Value
        3. Microbial Expression Systems
          1. By Value
        4. Yeast Expression Systems
          1. By Value
        5. Plant Expression Systems
          1. By Value
        6. Insect Expression Systems
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    5. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Active Pharmaceuticals Ingredients (APIs)
          1. By Value
        3. Biosimilars
          1. By Value
      2. By Products
        1. Introduction
          1. Products By Value
        2. Monoclonal antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Hormones and Growth Factors
          1. By Value
        5. Cytokines
          1. By Value
        6. Fusion Proteins
          1. By Value
        7. Therapeutic Enzymes
          1. By Value
        8. Blood Factors
          1. By Value
      3. By Expression System
        1. Introduction
          1. Expression System By Value
        2. Mammalian Expression Systems
          1. By Value
        3. Microbial Expression Systems
          1. By Value
        4. Yeast Expression Systems
          1. By Value
        5. Plant Expression Systems
          1. By Value
        6. Insect Expression Systems
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    5. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Active Pharmaceuticals Ingredients (APIs)
          1. By Value
        3. Biosimilars
          1. By Value
      2. By Products
        1. Introduction
          1. Products By Value
        2. Monoclonal antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Hormones and Growth Factors
          1. By Value
        5. Cytokines
          1. By Value
        6. Fusion Proteins
          1. By Value
        7. Therapeutic Enzymes
          1. By Value
        8. Blood Factors
          1. By Value
      3. By Expression System
        1. Introduction
          1. Expression System By Value
        2. Mammalian Expression Systems
          1. By Value
        3. Microbial Expression Systems
          1. By Value
        4. Yeast Expression Systems
          1. By Value
        5. Plant Expression Systems
          1. By Value
        6. Insect Expression Systems
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Active Pharmaceuticals Ingredients (APIs)
        1. By Value
      3. Biosimilars
        1. By Value
    3. By Products
      1. Introduction
        1. Products By Value
      2. Monoclonal antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Hormones and Growth Factors
        1. By Value
      5. Cytokines
        1. By Value
      6. Fusion Proteins
        1. By Value
      7. Therapeutic Enzymes
        1. By Value
      8. Blood Factors
        1. By Value
    4. By Expression System
      1. Introduction
        1. Expression System By Value
      2. Mammalian Expression Systems
        1. By Value
      3. Microbial Expression Systems
        1. By Value
      4. Yeast Expression Systems
        1. By Value
      5. Plant Expression Systems
        1. By Value
      6. Insect Expression Systems
        1. By Value
    5. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Active Pharmaceuticals Ingredients (APIs)
          1. By Value
        3. Biosimilars
          1. By Value
      2. By Products
        1. Introduction
          1. Products By Value
        2. Monoclonal antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Hormones and Growth Factors
          1. By Value
        5. Cytokines
          1. By Value
        6. Fusion Proteins
          1. By Value
        7. Therapeutic Enzymes
          1. By Value
        8. Blood Factors
          1. By Value
      3. By Expression System
        1. Introduction
          1. Expression System By Value
        2. Mammalian Expression Systems
          1. By Value
        3. Microbial Expression Systems
          1. By Value
        4. Yeast Expression Systems
          1. By Value
        5. Plant Expression Systems
          1. By Value
        6. Insect Expression Systems
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Biotech Ingredients Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. AstraZeneca Plc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbvie Inc.
    3. Boehringer Ingelheim International Gmbh
    4. Eli Lilly and Company
    5. Merck Kgaa
    6. Mylan N.V.
    7. Novartis International Ag
    8. Pfizer Inc.
    9. Sanofi S.A.
    10. Teva Pharmaceutical Industries Ltd.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market OverviewThe global bakery ingredients market size was worth USD 15,235 million in 2021 and is projected to reach USD 25,305 million by 2030, growing at a CAGR of 5.8% during the forecast period (2022–2030). Bakery ingredients are the essentia
Buy Now
Global Report
Bulk Food Ingredients Market Size The global bulk food ingredients market size was valued at USD 350.60 billion in 2024. It is projected to reach from USD 368.94 billion in 2025 to USD 554.71 billion by 2033, growing at a CAGR of
Buy Now
Global Report
Prebiotic Ingredient Market Size The global prebiotic ingredient market size was valued at USD 8.43 billion in 2024 and is projected to reach from USD 9.30 billion in 2025 to USD 20.54 billion by 2033, registering a CAGR of 10.41%  during
Buy Now
Global Report
Market OverviewThe global savory ingredients market size was valued at USD 9.04 billion in 2022. It is projected to reach USD 14.8 billion by 2031, growing with a CAGR of 5.7% during the forecast period (2023–2031). Savory ingredients are flavor mod
Buy Now
Global Report
Market OverviewThe global yeast ingredients market size was valued at USD 2.75 billion in 2023. It is estimated to reach USD 5.92 billion by 2032, growing at a CAGR of 8.90% during the forecast period (2024–2032). In recent years, consumers have incr
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.